Current concepts and significance of estrogen receptor β in prostate cancer

Steroids

Volumn 77, Issue 12, 2012, Pages 1262-1266

  Hartman, Johan ^a,b   Ström, Anders ^c   Gustafsson, Jan Åke ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c University of Houston   (United States)

Author keywords

Estrogen receptor beta; Phytoestrogens; Prostate cancer; Prostate cancer prevention; Targeted therapies

Indexed keywords

3BETA ANDROSTANEDIOL; DAIDZEIN; DUTASTERIDE; ESTROGEN RECEPTOR BETA; FINASTERIDE; FLAVONOID; GENISTEIN; ISOFLAVONE DERIVATIVE; LIGNAN; PHYTOESTROGEN; PLACEBO; RALOXIFENE; STEROID 5ALPHA REDUCTASE INHIBITOR; TAMOXIFEN; TOREMIFENE;

CANCER GROWTH; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER INHIBITION; DRUG TARGETING; HUMAN; LUNG METASTASIS; MEDICAL LITERATURE; NONHUMAN; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE PROGRESSION; ESTROGEN RECEPTOR BETA; HUMANS; MALE; PHYTOESTROGENS; PROSTATE; PROSTATIC NEOPLASMS;

EID: 84865645016     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2012.07.002     Document Type: Review

References (67)

1. F. Kamangar, G.M. Dores, and W.F. Anderson Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 14 2006 2137 2150
2. H.B. Carter, and J.T. Isaacs Overview of hormonal therapy for prostate cancer Prog Clin Biol Res 350 1990 129 140
3. A. Jemal Global cancer statistics CA Cancer J Clin 61 2 2011 69 90
4. T. Usui Pharmaceutical prospects of phytoestrogens Endocr J 53 1 2006 7 20
5. I.U. Agoulnik, and N.L. Weigel Androgen receptor action in hormone-dependent and recurrent prostate cancer J Cell Biochem 99 2 2006 362 372
6. W.Y. Chang, and G.S. Prins Estrogen receptor-beta: implications for the prostate gland Prostate 40 2 1999 115 124
7. P.B. Singh, S.S. Matanhelia, and F.L. Martin A potential paradox in prostate adenocarcinoma progression: oestrogen as the initiating driver Eur J Cancer 44 7 2008 928 936
8. Jensen E, Jacobsen HI. Fate of steroid estrogens in target tissues. In: Pincus G, Vollmer EP, editors. Biological activities of steroids in relation to cancer, 1960, New York: Academic Press; p. 161-174.
9. G.G. Kuiper Cloning of a novel receptor expressed in rat prostate and ovary Proc Natl Acad Sci USA 93 12 1996 5925 5930
10. P.T. Saunders Expression of oestrogen receptor beta (ER beta) in multiple rat tissues visualised by immunohistochemistry J Endocrinol 154 3 1997 R6 R13
11. J. Matthews, and J.A. Gustafsson Estrogen signaling: a subtle balance between ER alpha and ER beta Mol Interv 3 5 2003 281 292
12. J.M. Hall, and D.P. McDonnell Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting Mol Interv 5 6 2005 343 357
13. S. Ogawa Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor of estrogen action in human Nucleic Acids Res 26 15 1998 3505 3512
14. C. Zhao Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells Cancer Res 67 8 2007 3955 3962
15. Y.K. Leung Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion Endocr Relat Cancer 17 3 2010 675 689
16. T. Fixemer, K. Remberger, and H. Bonkhoff Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma Prostate 54 2 2003 79 87
17. E. Enmark Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern J Clin Endocrinol Metab 82 12 1997 4258 4265
18. L.P. Menasce Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique Genomics 17 1 1993 263 265
19. S. El Marzouk The plasticity of estrogen receptor-DNA complexes: binding affinity and specificity of estrogen receptors to estrogen response element half-sites separated by variant spacers J Steroid Biochem Mol Biol 110 1-2 2008 186 195
20. S. Nilsson, K.F. Koehler, and J.A. Gustafsson Development of subtype-selective oestrogen receptor-based therapeutics Nat Rev Drug Discov 10 10 2011 778 792
21. J.H. Krege Generation and reproductive phenotypes of mice lacking estrogen receptor beta Proc Natl Acad Sci USA 95 26 1998 15677 15682
22. G.R. Cunha Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development J Steroid Biochem Mol Biol 92 4 2004 221 236
23. S. Yeh Generation and characterization of androgen receptor knockout (ARKO) mice. an in vivo model for the study of androgen functions in selective tissues Proc Natl Acad Sci USA 99 21 2002 13498 13503
24. G.R. Cunha Mesenchymal-epithelial interactions: past, present, and future Differentiation 76 6 2008 578 586
25. G.R. Cunha, and B. Lung The importance of stroma in morphogenesis and functional activity of urogenital epithelium In Vitro 15 1 1979 50 71
26. A. Galani Androgen insensitivity syndrome: clinical features and molecular defects Hormones (Athens) 7 3 2008 217 229
27. L. Pylkkanen Prostatic dysplasia associated with increased expression of c-myc in neonatally estrogenized mice J Urol 149 6 1993 1593 1601
28. Y. Omoto Estrogen receptor alpha and imprinting of the neonatal mouse ventral prostate by estrogen Proc Natl Acad Sci USA 102 5 2005 1484 1489
29. Z. Weihua A role for estrogen receptor beta in the regulation of growth of the ventral prostate Proc Natl Acad Sci USA 98 11 2001 6330 6335
30. G. Risbridger Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium Dev Biol 229 2 2001 432 442
31. O. Imamov Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate Proc Natl Acad Sci USA 101 25 2004 9375 9380
32. S.J. McPherson The role of Eralpha and ERbeta in the prostate: insights from genetic models and isoform-selective ligands Ernst Schering Found Symp Proc 1 2006 131 147
33. R.L. Noble Prostate carcinoma of the Nb rat in relation to hormones Int Rev Exp Pathol 23 1982 113 159
34. Y. Wang Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue Cancer Res 60 21 2000 6008 6017
35. W.A. Ricke Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling FASEB J 22 5 2008 1512 1520
36. L.G. Horvath Frequent loss of estrogen receptor-beta expression in prostate cancer Cancer Res 61 14 2001 5331 5335
37. H. Bonkhoff Estrogen receptor expression in prostate cancer and premalignant prostatic lesions Am J Pathol 155 2 1999 641 647
38. H. Bonkhoff Progesterone receptor expression in human prostate cancer: correlation with tumor progression Prostate 48 4 2001 285 291
39. D.C. Leitman Tissue-specific regulation of genes by estrogen receptors Semin Reprod Med. 30 1 2012 14 22
40. S. Muthusamy Estrogen receptor beta and 17beta-hydroxysteroid dehydrogenase type 6, a growth regulatory pathway that is lost in prostate cancer Proc Natl Acad Sci USA 108 50 2011 20090 20094
41. E. Torlakovic Prostate carcinoma expression of estrogen receptor-beta as detected by PPG5/10 antibody has positive association with primary Gleason grade and Gleason score Hum Pathol 33 6 2002 646 651
42. A. Hsu Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells Exp Biol Med (Maywood) 235 1 2010 90 97
43. J.H. Mitchell, S.J. Duthie, and A.R. Collins Effects of phytoestrogens on growth and DNA integrity in human prostate tumor cell lines: PC-3 and LNCaP Nutr Cancer 38 2 2000 223 228
44. N.S. Shenouda Phytoestrogens in common herbs regulate prostate cancer cell growth in vitro Nutr Cancer 49 2 2004 200 208
45. J.V. Turner, S. Agatonovic-Kustrin, and B.D. Glass Molecular aspects of phytoestrogen selective binding at estrogen receptors J Pharm Sci 96 8 2007 1879 1885
46. M. Hedelin Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden) Cancer Causes Control 17 2 2006 169 180
47. M.F. Aguero Phenoxodiol inhibits growth of metastatic prostate cancer cells Prostate 70 11 2010 1211 1221
48. Y. Li Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells Cancer Res 65 15 2005 6934 6942
49. K. Kato Suppressive effects of dietary genistin and daidzin on rat prostate carcinogenesis Jpn J Cancer Res 91 8 2000 786 791
50. R. Mentor-Marcel Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP) Cancer Res 61 18 2001 6777 6782
51. R.K. Severson A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii Cancer Res 49 7 1989 1857 1860
52. I.Y. Kim Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines Cancer Res 62 18 2002 5365 5369
53. B.L. Neubauer Raloxifene (LY156758) produces antimetastatic responses and extends survival in the PAIII rat prostatic adenocarcinoma model Prostate 27 4 1995 220 229
54. Price, D., et al., Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial. J Urol 2006; 176(3): p. 965-70 [discussion 970-1].
55. M.K. Chadha Phase II study of fulvestrant (Faslodex) in castration resistant prostate cancer Prostate 68 13 2008 1461 1466
56. M.R. Smith Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical study J Urol 179 1 2008 152 155
57. S. Aggarwal An overview on 5alpha-reductase inhibitors Steroids 75 2 2009 109 153
58. G.L. Andriole Effect of dutasteride on the risk of prostate cancer N Engl J Med 362 13 2010 1192 1202
59. I.M. Thompson The influence of finasteride on the development of prostate cancer N Engl J Med 349 3 2003 215 224
60. Z. Weihua An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth Proc Natl Acad Sci USA 99 21 2002 13589 13594
61. D. Dondi Estrogen receptor beta and the progression of prostate cancer: role of 5alpha-androstane-3beta,17beta-diol Endocr Relat Cancer 17 3 2010 731 742
62. P. Mak ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading Cancer Cell 17 4 2010 319 332
63. O. Imamov, N.A. Lopatkin, and J.A. Gustafsson Estrogen receptor beta in prostate cancer N Engl J Med 351 26 2004 2773 2774
64. D. Nojima CpG hypermethylation of the promoter region inactivates the estrogen receptor-beta gene in patients with prostate carcinoma Cancer 92 8 2001 2076 2083
65. T.J. Walton DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines Prostate 68 2 2008 210 222
66. C. Zhao Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation Oncogene 22 48 2003 7600 7606
67. A. Latil Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays Cancer Res 61 5 2001 1919 1926